Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.
Pyridinolcarbamate
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
1987
Review
1987
Pentoxifylline (oxpentifylline) is an orally active haemorheological agent for the treatment of peripheral vascular disease… Expand
1977
1977
Abstract KK mice with genetic diabetic glomerulosclerosis were treated with 250 mg/kg of pyridinolcarbamate (PDC), an… Expand
Highly Cited
1973
Highly Cited
1973
Abstract Effects of histamine, bradykinin and morphine on adrenaline secretion from rat adrenal gland were investigated by means… Expand
1971
1971
A histoenzymatic study was carried out to elucidate the anti‐atherosclerotic effect of estrogen and pyridinolcarbamate, which has… Expand
1971
1971
The antiatherosclerotic effects of pyridinolcarbamate and estrogen, both of which have a preventative effect against acute… Expand
1970
1970
The antiatherosclerotic effect of pyridinolcarbamate in man has been subjected to the present controlled clinical trial in 43… Expand
1969
1969
Electron microscopical analysis of endothelial linings of the aortic lumen and of the vasa vasorum was made in man, rhesus monkey… Expand
1969
1969
Pyridinolcarbamate was used to prevent atherosclerosis formation in experimental animals.
Twenty-four male, albino rabbits… Expand
Highly Cited
1966
Highly Cited
1966
Abstract An antibradykinin and antilysylbradykinin agent, pyridinolcarbamate (2,6-bis-hydroxymethylpyridine- bis N… Expand
1966
1966
Abstract Pyridinolcarbamate (2,6-bis (hydroxymethyl)pyridine-bis(N-methylcarbamate) is a nontoxic and weak basic synthetic… Expand